Provided by Tiger Trade Technology Pte. Ltd.

INmune Bio Inc

2.31
-0.0250-1.07%
Volume:221.14K
Turnover:502.00K
Market Cap:63.97M
PE:-3.32
High:2.33
Open:2.32
Low:2.21
Close:2.33
52wk High:2.50
52wk Low:1.09
Shares:27.75M
Float Shares:23.19M
Volume Ratio:1.28
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6937
EPS(LYR):-1.8600
ROE:-74.82%
ROA:-39.12%
PB:3.14
PE(LYR):-1.24

Loading ...

INmune Bio Submits EMA Orphan Drug Application for Ebstrocel in RDEB

Reuters
·
Aug 26

INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with Ema Regulatory Filings

THOMSON REUTERS
·
Aug 26

INmune Bio - Company Targets UK Maa in Q4 2026, EU Maa and U.S. Bla in Q1 2027

THOMSON REUTERS
·
Aug 26

INmune Bio Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

INmune Bio Q2 Net Loss Narrows on Lower Impairment Charges

Reuters
·
Aug 07

INmune Bio Q2 EPS $(0.05) Beats $(0.21) Estimate

Benzinga Earnings
·
Aug 07

INmune Bio Q2 Basic EPS USD -0.05

THOMSON REUTERS
·
Aug 07

INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress

THOMSON REUTERS
·
Aug 07

INmune Bio Inc Expected to Post a Loss of 21 Cents a Share - Earnings Preview

Reuters
·
Aug 05

INmune Bio Receives R&D Rebates of Approximately $4.6 Million

THOMSON REUTERS
·
Jul 31

INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6TH

THOMSON REUTERS
·
Jul 31

INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th

GlobeNewswire
·
Jul 31

INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform

GlobeNewswire
·
Jul 30

INmune Bio Meets Milestone for CORDStrom Platform; Plans to Apply for BLA With US FDA

MT Newswires Live
·
Jul 20

Inmune Bio Reports Press Release Available

Reuters
·
Jul 20

Inmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for Cordstrom™ Platform

THOMSON REUTERS
·
Jul 20

INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform

GlobeNewswire
·
Jul 20

INmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury

MT Newswires Live
·
Jul 15

Inmune Bio - Cordstrom to File Maa with UK Mhra and EU Ema in 2026; U.S. Bla Planned

THOMSON REUTERS
·
Jul 15

Inmune Bio - Xpro1595 Selectively Neutralizes Soluble Tnf

THOMSON REUTERS
·
Jul 15